Skip to content
Agree.net – Lifestyle
Author:
XVIVO Perfusion AB
Interim Report January – June 2026
July 14, 2026
Conference call on Interim Report April-June 2026
June 26, 2026
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO’s Heart Technology
May 18, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 27, 2026
Interim Report January – March 2026
April 24, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 22, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 22, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
Annual Report 2025
April 1, 2026
1
2
Next Page
→